What is the difference between Briviact and Keppra?
Official Answer
by Drugs.comBriviact (brivaracetam) and Keppra (levetiracetam) are anticonvulsant medicines that target the synaptic vesicle protein 2A (SV2A) in the brain. The newer agent Briviact is noted to be more selective and has a higher affinity for this receptor than Keppra.
Briviact and Keppra are both used as monotherapy for the treatment of partial-onset seizures.
Keppra is also used as adjunctive therapy for the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy, and as adjunctive therapy for the treatment of primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy.
Keppra XR is an extended release tablet formulation used for the treatment of partial-onset seizures in patients 12 years of age and older.
| Briviact | Keppra | |
|---|---|---|
| Dosage Forms |
|
|
| Indications |
Oral formulations and Injection
|
Oral formulations and Injection
|
| Side Effects | Common side effects include somnolence/sedation, dizziness, fatigue, and nausea/vomiting. | Common side effects include somnolence, asthenia, infection, dizziness, and irritability. |
Related Medical Questions
- How long does it take to get Keppra out of your system?
- Aptiom vs Keppra, what is the difference?
- What type of epilepsy is Diacomit used to treat?